Technology-assisted Case Management in Adults With Type 2 Diabetes (TACM-DM)
Primary Purpose
Diabetes
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Technology-Assisted Case Management
Sponsored by

About this trial
This is an interventional treatment trial for Diabetes focused on measuring type 2 diabetes, nurse case management, telemedicine
Eligibility Criteria
Inclusion Criteria:
- Age ≥18 years and receiving care within the Franklin C. Fetter Family Health Center
- Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
- Subject must be willing to use the FORA 2-in-1 system
- Subject must have a working land-line for the duration of the study in order to be able to upload the readings from the FORA 2-in-1 machine
- Subjects must be able to communicate in English
Exclusion Criteria:
- Mental confusion on interview suggesting significant dementia
- Participation in other diabetes clinical trials
- Alcohol or drug abuse/dependency using a screening questionnaire
- Active psychosis or acute mental disorder
- Life expectancy <6 months
- Pregnant and/or lactating females
Sites / Locations
- Franklin C. Fetter Family Health Center, Inc.
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Usual Care
Technology Assisted Case Management
Arm Description
The usual care group received the current standards of care at the study clinics.
The TACM group used the FORA 2-in-1 Telehealth system for diabetes management intervention to link a case manager to patients with poorly controlled type 2 diabetes in real time.
Outcomes
Primary Outcome Measures
Hemoglobin A1c (HbA1c) at 6 Months Post Randomization
Hemoglobin A1c (HbA1c) was measured at 6 months post randomization
Secondary Outcome Measures
Full Information
NCT ID
NCT01373489
First Posted
June 13, 2011
Last Updated
August 7, 2023
Sponsor
Medical College of Wisconsin
Collaborators
United States Department of Defense
1. Study Identification
Unique Protocol Identification Number
NCT01373489
Brief Title
Technology-assisted Case Management in Adults With Type 2 Diabetes
Acronym
TACM-DM
Official Title
Effectiveness of Technology-Assisted Case Management in Low Income Adults With Type 2 Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical College of Wisconsin
Collaborators
United States Department of Defense
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to help low income patients achieve and maintain better self-management skills and improve blood sugar levels, using a 2-in-1 blood glucose and blood pressure monitoring system and nurse case management. Patients must be served at a Federally Qualified Health Center (FQHC) in coastal South Carolina.
Detailed Description
The long-term goal is to develop a practical and sustainable system of diabetes management that will help low income patients achieve and maintain goals within established treatment guidelines regardless of geographic location. This randomized clinical trial will employ the innovative FORA system, an inexpensive, off-the-shelf, state-of-the-art technology comprised of a 2-in-1 Blood Glucose and Blood Pressure monitor, coupled with nurse case management (TACM) to optimize diabetes care for low income, rural adults with type 2 diabetes (T2DM). The target population will be low income patients served in Federally Qualified Health Care Centers (FQHCs) with poorly controlled T2DM residing in coastal South Carolina. Two hundred patients will be randomly assigned to two groups of 100 patients each; Group A (Usual Care) and Group B (Technology-assisted Case Management, TACM). Each patient will be followed for 6 months, with study visits at baseline, 3, and 6 months. The primary outcome will be Hemoglobin A1c (HbA1c) at 6 months post-randomization while the secondary outcomes will be blood pressure control and quality of life (qol) at 6 months post-randomization.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes
Keywords
type 2 diabetes, nurse case management, telemedicine
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
113 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
The usual care group received the current standards of care at the study clinics.
Arm Title
Technology Assisted Case Management
Arm Type
Experimental
Arm Description
The TACM group used the FORA 2-in-1 Telehealth system for diabetes management intervention to link a case manager to patients with poorly controlled type 2 diabetes in real time.
Intervention Type
Behavioral
Intervention Name(s)
Technology-Assisted Case Management
Intervention Description
The TACM intervention uses the FORA 2-in-1 Telehealth System for diabetes to link a case manager to poorly controlled diabetics in real time. Patients will be assigned the FORA 2-in-1 Telehealth System and provided glucose test strips to allow testing at least once a day. They will be asked to perform glucose testing and blood pressure measurement using the FORA system once daily. They will be asked to upload the measurements daily as soon as possible after the test is performed. The nurse case manager will have access to a secure server to which the uploaded measurements are stored in real time. Medications are titrated under supervision of a primary care and endocrinology physicians
Primary Outcome Measure Information:
Title
Hemoglobin A1c (HbA1c) at 6 Months Post Randomization
Description
Hemoglobin A1c (HbA1c) was measured at 6 months post randomization
Time Frame
6 months post randomization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
120 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥18 years and receiving care within the Franklin C. Fetter Family Health Center
Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
Subject must be willing to use the FORA 2-in-1 system
Subject must have a working land-line for the duration of the study in order to be able to upload the readings from the FORA 2-in-1 machine
Subjects must be able to communicate in English
Exclusion Criteria:
Mental confusion on interview suggesting significant dementia
Participation in other diabetes clinical trials
Alcohol or drug abuse/dependency using a screening questionnaire
Active psychosis or acute mental disorder
Life expectancy <6 months
Pregnant and/or lactating females
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leonard E Egede, MD, MS
Organizational Affiliation
Medical College of Wisconsin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Franklin C. Fetter Family Health Center, Inc.
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29403
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22014122
Citation
Egede LE, Strom JL, Fernandes J, Knapp RG, Rojugbokan A. Effectiveness of technology-assisted case management in low income adults with type 2 diabetes (TACM-DM): study protocol for a randomized controlled trial. Trials. 2011 Oct 20;12:231. doi: 10.1186/1745-6215-12-231.
Results Reference
background
PubMed Identifier
28581821
Citation
Egede LE, Williams JS, Voronca DC, Knapp RG, Fernandes JK. Randomized Controlled Trial of Technology-Assisted Case Management in Low Income Adults with Type 2 Diabetes. Diabetes Technol Ther. 2017 Aug;19(8):476-482. doi: 10.1089/dia.2017.0006. Epub 2017 Jun 5.
Results Reference
result
Links:
URL
https://pubmed.ncbi.nlm.nih.gov/22014122/
Description
Protocol Paper
URL
https://pubmed.ncbi.nlm.nih.gov/28581821/
Description
Primary Outcomes Paper
Learn more about this trial
Technology-assisted Case Management in Adults With Type 2 Diabetes
We'll reach out to this number within 24 hrs